[HTML][HTML] Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease
LC Johnston, X Su, K Maguire-Zeiss, K Horovitz… - Molecular Therapy, 2008 - cell.com
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
[HTML][HTML] Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
LC Johnston, X Su, K Maguire-Zeiss… - … therapy: the journal …, 2008 - ncbi.nlm.nih.gov
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dop-aminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dop-aminergic neurodegeneration. In models of PD, microglial activation …
[PDF][PDF] Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
LC Johnston, X Su, K Maguire-Zeiss, K Horovitz… - Mol Ther, 2008 - researchgate.net
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dop-aminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dop-aminergic neurodegeneration. In models of PD, microglial activation …
[HTML][HTML] Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
LC Johnston, X Su, K Maguire-Zeiss, K Horovitz… - Molecular Therapy, 2008 - Elsevier
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
Human interleukin-10 gene transfer is protective in a rat model of parkinson's disease
LC Johnston, X Su, K Maguire-Zeiss… - Molecular …, 2008 - ohiostate.elsevierpure.com
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
[引用][C] Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
LC Johnston, X Su, K Maguire-Zeiss, K Horovitz… - Molecular …, 2008 - cir.nii.ac.jp
[PDF][PDF] Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
K Maguire-Zeiss, P Hadaczek, H Federoff, J Forsayeth - Mol Ther, 2008 - academia.edu
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dop-aminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dop-aminergic neurodegeneration. In models of PD, microglial activation …
Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease.
LC Johnston, X Su, K Maguire-Zeiss… - Molecular …, 2008 - search.ebscohost.com
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
Human interleukin-10 gene transfer is protective in a rat model of parkinson's disease
LC Johnston, X Su, K Maguire-Zeiss… - Molecular …, 2008 - research.nu.edu.kz
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
LC Johnston, X Su, K Maguire-zeiss… - Molecular …, 2008 - search.proquest.com
In Parkinson's disease (PD) chronic inflammation occurs in the substantia nigra (SNc)
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …
concurrently with dopaminergic neurodegeneration. In models of PD, microglial activation …